- Home
- MRNA vs PNW Comparison
MRNA vs PNW Comparison
Compare MRNA & PNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- PNW
- Stock Information
- Founded
- MRNA 2010
- PNW 1985
- Country
- MRNA United States
- PNW United States
- Employees
- MRNA N/A
- PNW N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- PNW Electric Utilities: Central
- Sector
- MRNA Health Care
- PNW Utilities
- Exchange
- MRNA Nasdaq
- PNW Nasdaq
- Market Cap
- MRNA 9.8B
- PNW 10.3B
- IPO Year
- MRNA 2018
- PNW N/A
- Fundamental
- Price
- MRNA $25.18
- PNW $88.53
- Analyst Decision
- MRNA Hold
- PNW Buy
- Analyst Count
- MRNA 15
- PNW 13
- Target Price
- MRNA $37.15
- PNW $96.23
- AVG Volume (30 Days)
- MRNA 10.8M
- PNW 1.1M
- Earning Date
- MRNA 11-06-2025
- PNW 11-03-2025
- Dividend Yield
- MRNA N/A
- PNW 4.04%
- EPS Growth
- MRNA N/A
- PNW N/A
- EPS
- MRNA N/A
- PNW 4.81
- Revenue
- MRNA $3,078,000,000.00
- PNW $5,255,240,000.00
- Revenue This Year
- MRNA N/A
- PNW $4.14
- Revenue Next Year
- MRNA $11.12
- PNW $4.87
- P/E Ratio
- MRNA N/A
- PNW $18.39
- Revenue Growth
- MRNA N/A
- PNW 7.47
- 52 Week Low
- MRNA $23.15
- PNW $81.47
- 52 Week High
- MRNA $56.70
- PNW $96.50
- Technical
- Relative Strength Index (RSI)
- MRNA 44.51
- PNW 37.17
- Support Level
- MRNA $24.25
- PNW $91.54
- Resistance Level
- MRNA $29.20
- PNW $93.39
- Average True Range (ATR)
- MRNA 1.50
- PNW 1.42
- MACD
- MRNA -0.13
- PNW -0.61
- Stochastic Oscillator
- MRNA 16.97
- PNW 15.35
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility serving approximately 1.4 million customers across a 35,000-square-mile territory in central Arizona, including the Phoenix area. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.